Cargando…

Hospital readmission with Clostridium difficile infection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis: A retrospective cohort study

Recurrent Clostridium difficile infection (rCDI) requiring rehospitalization contributes to poor outcomes, which may differ between patients hospitalized with versus for it. We performed a multicenter retrospective cohort study of rehospitalized adults surviving initial CDI hospitalization. Hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilberberg, Marya D., Nathanson, Brian H., Marcella, Stephen, Hawkshead, John Jay, Shorr, Andrew F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133633/ https://www.ncbi.nlm.nih.gov/pubmed/30200134 http://dx.doi.org/10.1097/MD.0000000000012212

Ejemplares similares

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Assessment of Reporting Bias for Clostridium difficile Hospitalizations, United States
por: Zilberberg, Marya D.
Publicado: (2008)

Clostridium difficile–related Hospitalizations among US Adults, 2006
por: Zilberberg, Marya D.
Publicado: (2009)

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Recurrent Clostridium difficile infection among Medicare patients in nursing homes: A population-based cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2017)

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006
por: Zilberberg, Marya D., et al.
Publicado: (2010)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis
por: Lee, Helen S., et al.
Publicado: (2021)

1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

1501. Risk Factors for Clostridium difficile Infection in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey
por: Heinrich, Kirstin, et al.
Publicado: (2018)

Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018
por: Zilberberg, Marya D, et al.
Publicado: (2022)

Advances in the diagnosis and treatment of Clostridium difficile infections
por: Peng, Zhong, et al.
Publicado: (2018)

Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis
por: Bai, Yuanyuan, et al.
Publicado: (2017)

Epidemiology and Outcomes of Hospitalizations with Invasive Aspergillosis in the United States, 2010–2013
por: Zilberberg, Marya D, et al.
Publicado: (2017)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

2817. Outcomes of Timely vs. Delayed Meropenem/Vaborbactam Treatment of Infections with CRE among Adults Hospitalized in the US, 2019-2021
por: Zilberberg, Marya D, et al.
Publicado: (2023)

2816. Comparative Effectiveness of Meropenem/Vaborbactam vs. Ceftazidime/Avibactam among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease
por: Zhang, Ting, et al.
Publicado: (2016)

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Recent Advances in the Diagnosis and Treatment of Clostridium Difficile Infection
por: Avila, Meera B., et al.
Publicado: (2016)

Current knowledge on the laboratory diagnosis of Clostridium difficile infection
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2017)

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Corrigendum: Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease
por: Zhang, Ting, et al.
Publicado: (2017)

Diagnosis of Clostridium difficile infection by toxigenic culture and PCR assay
por: Mirzaei, Elnaze Zare, et al.
Publicado: (2018)

468. Diagnosis of Clinical Clostridium difficile Infection: An Unmet Challenge
por: Vyas, Neeti, et al.
Publicado: (2018)

Early diagnosis and antibiotic treatment for fulminant Clostridium difficile infection
por: Fukushima, Kazutaka, et al.
Publicado: (2020)

2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study
por: Zilberberg, Marya, et al.
Publicado: (2019)

Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study
por: Zilberberg, Marya D, et al.
Publicado: (2019)

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fa5mcajssn9rth3fgb7u7bgpc9